Half-year Results
H1 2025: revenue £7,600, loss £221,308; raised £1.6m post-period, invested £950,000 in Alludium.
- Revenue £7,600 (prior £124,500)
- Loss for period £221,308 (prior £12,778)
- Net assets £1,016,661 (prior £566,764)
- Cash £94,092 (prior £4,759)
- Post-period fundraise £1.6m gross proceeds
Select text to share a quote on X · sign in to keep highlights & notes in your CTAI notes
Catenai PLC (AIM: CTAI), the AIM quoted provider of digital media and technology, announces its half-yearly report for the six months ended 30 June 2025.
Financial overview
- Loss of £221,308 in the period under review (H1 2024: £12,778) with revenues of £7,600 (H1 2024: £124,500).
- Net asset position £1,016,661 (H1 2024: £566,764).
- Cash position of £94,092 as at 30 June 2025 (H1 2024: £4,759).
- In July 2025, the Company completed a fundraise raising gross proceeds of £1.6m.
The Company continues to service its customer in the sports sector.
On 11 April 2025, the Company announced that it had identified an opportunity to invest in Alludium Ltd ("Alludium"), a cutting-edge AI company. Following a fundraise, an initial investment of £500,000 was made into Alludium.
On 26 June 2025, the Company announced a fundraising and launch of a Bitcoin-focused treasury policy together with a proposed £450,000 additional investment in Alludium.
On 30 June 2025, the Company announced that Klarian Ltd had extended its loan repayment with new terms depending on when repayment is made.
Post period end
The second investment of £450,000 into Alludium was completed on 17 July 2025.
The foundations for our Bitcoin focused treasury function were announced on 28 July 2025 and a second institutional custodian is being onboarded. Market and regulatory conditions are being monitored.
Our investment in Alludium continues to demonstrate strong momentum as they pioneer the no-code AI agent workforce category. Since their announcement in May 2025, Alludium has achieved significant key product milestones and we look forward to the product being available to their public waitlist later next month. Their differentiated approach-creating AI agents that work together in teams, alongside humans, that autonomously execute tasks rather than just chat-has resonated strongly with early design partners. The controlled rollout strategy is progressing well, with the platform transitioning from alpha to public release in October 2025. With strategic positioning at major technology industry events in Q4 including SAASstock, WebSummit Lisbon, and Slush, Alludium is well-positioned to capture significant value in the rapidly expanding autonomous AI market, addressing the critical gap between conversational AI and true task automation.
Klarian have advised the Company that they expect to repay the loan in full before 31 December 2025 in accordance with the revised terms announced on 30 June 2025 and so an extension fee of £56,750 will be due and recognised in the annual results to 31 December 2025.
John Farthing, Interim CEO, commented: "We look forward to the launch of Alludium's platform which is timely given the strong endorsement of AI by the UK Government."
Statement of Comprehensive Income
For the Period Ended 30 June 2025
| Unaudited six months ended 30 June 2025 £ | Unaudited six months ended 30 June 2024 £ | Audited year ended 31 December 2024 £ | |
|---|---|---|---|
| Revenue | 7,600 | 124,500 | 131,500 |
| Cost of sales | - | - | - |
| Gross profit | 7,600 | 124,500 | 131,500 |
| Administrative expenses | (228,994) | (137,278) | (262,679) |
| Loss from operations | (221,394) | (12,778) | (131,179) |
| Net Finance income | 86 | - | 3005 |
| Loss before taxation | (221,308) | (12,778) | (128,174) |
| Taxation | - | - | - |
| Total comprehensive loss for the period | (221,308) | (12,778) | (128,174) |
| Statement of Financial Position | |||
| For the Period Ended 30 June 2025 | |||
| Unaudited six months ended 30 June 2025 £ | Unaudited six months ended 30 June 2024 £ | Audited year ended 31 December 2024 £ | |
| Non-current assets | |||
| Intangible assets Investment | 1 500,000 | 1 - | 1 - |
| 500,001 | 1 | 1 | |
| Current assets | |||
| Trade and other receivables | 676,254 | 627,205 | 578,321 |
| Cash and cash equivalents | 94,092 | 4,759 | 477 |
| 770,346 | 631,964 | 578,798 | |
| Current liabilities | |||
| Trade and other payables | (213,686) | (65,201) | (174,230) |
| Loans and borrowings | (40,000) | - | |
| (253,686) | (65,201) | (174,230) | |
| Non-current liabilities | |||
| Interest-bearing loans | - | - | - |
| Total Liabilities | (253,686) | (65,201) | (174,230) |
| Net Assets | 1,016,661 | 566,764 | 404,568 |
Capital and reserves attributable to equity holders of the company
| Unaudited six months ended 30 June 2025 £ | Unaudited six months ended 30 June 2024 £ | Audited year ended 31 December 2024 £ | |
|---|---|---|---|
| Ordinary share capital | 96,329 | 789,149 | 789,149 |
| Deferred share capital | 4,387,684 | 3,615,192 | 3,615,192 |
| Share premium account | 20,709,953 | 20,003,024 | 19,956,224 |
| Share reserve | (83,333) | (83,333) | (83,333) |
| Merger reserve | 11,119,585 | 11,119,585 | 11,119,585 |
| Capital Redemption Reserve | 2,732,904 | 2,732,904 | 2,732,904 |
| Retained losses | (37,946,461) | (37,609,757) | (37,725,153) |
| Total Equity | 1,016,661 | 566,764 | 404,568 |
| Statement of Cash Flows | |||
| For the Period Ended 30 June 2025 | |||
| Unaudited six months ended 30 June 2025 £ | Unaudited six months ended 30 June 2024 £ | Audited year ended 31 Dec 2024 £ | |
| Loss for the period | (221,308) | (12,778) | (128,174) |
| Adjustments for : Services settled by the issue of shares | 88,400 | - | - |
| Net cash outflow before changes in working capital | (132,908) | (12,778) | (128,174) |
| (Increase) / decrease in trade and other receivables | (97,933) | (109,914) | (561,029) |
| (Decrease) / increase in trade and other payables | 39,456 | (93,734) | 15,295 |
| Cash from operations | (191,385) | (216,426) | (673,908) |
| Financing Activities | |||
| Issue of ordinary share capital Share issue costs | 786,000 (41,000) | 670,000 - | 720,000 (46,800) |
| Issue of CLN | - | (450,000) | - |
| New loans raised Investment | 40,000 (500,000) | - - | - - |
| Net cash flows from financing activities | 285,000 | 220,000 | 673,200 |
| Net increase / (decrease) in cash | 93,615 | 3,574 | (708) |
| Cash and cash equivalents at beginning of period | 477 | 1,185 | 1,185 |
| Cash and cash equivalents at end of period | 94,092 | 4,759 | 477 |
Caution regarding forward looking statements
Cleaned text: letterheads, contacts and legal notices removed. View the original announcement ↗ · Company filings. Not investment advice.